Note 9 – Share Based Compensation

At September 30, 2013, the Company had two share based compensation plans in existence, the 1999 Stock Option Plan (expired but having outstanding options that may still be exercised) and the 2005 Omnibus Stock Plan, which is described below.

The Company’s 2005 Omnibus Stock Plan (“Omnibus Plan”) provides for the granting of non-qualifying stock options to the Company’s directors, and incentive and non-qualifying stock options, stock appreciation rights and restricted stock grants to selected key employees on a periodic basis at the discretion of the board. The Omnibus Plan authorizes the issuance of up to 1,800,000 shares of common stock of which 998,375 are available for issuance at September 30, 2013, has a term of ten years, and is administered by a committee of at least three directors appointed by the board of directors. Options granted under the plan have an exercise price which may not be less than 100% of the fair market value of the common stock on the date of the grant and must be exercised within seven to ten years from the date of grant. The exercise price of stock options must be paid for in full in cash or shares of common stock, or a combination of both. The Stock Option Committee has the discretion when making a grant of stock options to impose restrictions on the shares to be purchased upon the exercise of such options. Options granted under the expired 1999 Stock Option Plan remain outstanding until exercised or they expire. The Company generally issues authorized but previously unissued shares to satisfy option exercises.

The fair values of all of the options granted for the periods indicated have been estimated using a binomial option-pricing model with the weighted-average assumptions for the periods shown are presented in the following table:

	Nine Months Ended September 30,
	2013			2012
Dividend yield		2.80	%		2.17	%
Weighted average expected volatility		53.87	%		50.90	%
Weighted average risk-free interest rate		0.83	%		1.14	%
Weighted average expected lives (in years)		5.34			5.35
Weighted average grant-date fair value	$	7.99		$	7.85

The dividend yield is based on estimated future dividend yields. The risk-free rate for periods within the contractual term of the share option is based on the U.S. Treasury yield curve in effect at the time of the grant. Expected volatilities are generally based on historical volatilities. The expected term of share options granted is generally derived from historical experience.

Compensation expense is recognized on a straight-line basis over the vesting period of the respective stock option or restricted stock grant. The Company recognized compensation expense of $0.4 million and $0.4 million for the three months ended September 30, 2013 and 2012, respectively, related to the awards of stock options and restricted stock grants. Compensation expense of $1.2 million and $1.0 million was recognized for the nine months ended September 30, 2013 and 2012, respectively. Stock options exercised were 10,964 and 1,217 for the nine months ended September 30, 2013 and 2012, respectively. The intrinsic value for any exercised stock options in 2013 and 2012 was not significant. The total of unrecognized compensation cost related to stock options was approximately $0.3 million as of September 30, 2013. That cost is expected to be recognized over a weighted average period of approximately 1.7 years. The total of unrecognized compensation cost related to restricted stock was approximately $3.6 million as of September 30, 2013. That cost is expected to be recognized over a weighted average period of approximately 3.1 years. The fair value of the options vested during the three months ended September 30, 2013 and 2012, was $0.2 million and $0.2 million, respectively.

In the first quarter of 2013, 20,229 stock options were granted, subject to a three year vesting schedule with one third of the options vesting each year on the anniversary date of the grant. Additionally, 93,770 shares of restricted stock were granted, subject to a five year vesting schedule with one fifth of the shares vesting each year on the grant date anniversary.

A summary of share option activity for the period indicated is reflected in the following table:

					Weighted
	Number		Weighted		Average		Aggregate
	of		Average		Contractual		Intrinsic
	Common		Exercise		Remaining		Value
	Shares		Share Price		Life(Years)		(in thousands)
Balance at January 1, 2013		440,453	$	29.17			$	557
Granted		20,229	$	20.26			$	-
Exercised		(10,964)	$	12.70			$	-
Forfeited or expired		(4,962)	$	34.29			$	-
Balance at September 30, 2013		444,756	$	29.11		1.9	$	1,032

Exercisable at September 30, 2013		399,221	$	30.21		1.5	$	861

Weighted average fair value of options granted during the year			$	7.99

A summary of the activity for the Company’s non-vested options for the period indicated is presented in the following table:

			Weighted
			Average
	Number		Grant-Date
(In dollars, except share data):	of Shares		Fair Value
Non-vested options at January 1, 2013		54,416		$7.56
Granted		20,229	$	7.99
Vested		(29,110)	$	7.34
Forfeited or expired		-		-
Non-vested options at September 30, 2013		45,535	$	7.89

A summary of the activity for the Company’s restricted stock for the period indicated is presented in the following table:

			Weighted
			Average
	Number		Grant-Date
(In dollars, except share data):	of Shares		Fair Value
Restricted stock at January 1, 2013	224,005		$	17.40
Granted		93,770	$	20.26
Vested		(71,455)	$	17.06
Forfeited		(17,187)	$	18.24
Restricted stock at September 30, 2013		229,133	$	18.61